Industry Research: Medical Schemes

Image placeholder
Credit Outlook on South African Medical Schemes Amidst The COVID-19 Pandemic
  • Industry Research: Medical Schemes
  • Year : Mar 2020
Access Now
Summary

Despite potential earnings strain, GCR expects most rated schemes to remain resilient, given sufficient reserve buffers, although schemes with lower reserves may be vulnerable to further weakening.

 

Additional Information

Over the past five years, GCR’s rated sample of South African Medical Schemes has evidenced financial resilience amidst challenging economic conditions and an uncertain regulatory backdrop. GCR views industry solvency and reserve management to be prudent, although reserve buffers may moderate given potential earnings pressure associated with COVID-19, which could persist for a prolonged period.

Related Publication

Credit Outlook on South African Medical Schemes Amidst The COVID-19 Pandemic

Despite potential earnings strain, GCR expects most rated schemes to remain resilient, given sufficient reserve buffers, although schemes with lowe...

Hosmed Medical Scheme

Hosmed's national scale financial strength rating reflects the scheme’s adequate solvency and strong liquidity. Offsetting these is the l...

SECURITISATION 101

Securitisation is seen as an alternative to on-balance sheet funding and a form of disintermediation, allowing corporates and other institutions to...

Available Purchase Options: